Correction to: Pharmacoeconomics 2012; 30(11): 1067–1084 https://doi.org/10.2165/11595080-000000000-00000
Unfortunately, the article’s Supplementary File Link is not working and the ESM material is missing from the published article. The correct version is updated here.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Panattoni, L., Brown, P.M., Ao, B.T. et al. Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes. PharmacoEconomics 38, 315 (2020). https://doi.org/10.1007/s40273-020-00885-8